Technical considerations and review of urinary microRNAs as biomarkers for chronic kidney disease in dogs and cats
Veterinary Clinical Pathology · 2025
DOI: 10.1111/vcp.13412 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Veterinary Clinical Pathology, 2025. Verfasst von Candice P Chu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Pathobiology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas, USA. Hauptthemen laut MEDLINE: MicroRNAs, Renal Insufficiency, Chronic, Cat Diseases, Dog Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 181 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
MicroRNAs (miRNAs or miRs) are small, non‐coding RNAs that play a crucial role in gene regulation, making them potential biomarkers for various diseases. In the field of veterinary medicine, there is a growing interest in exploring the diagnostic and therapeutic potential of miRNAs in kidney diseases affecting dogs and cats. This review focuses on the use of urinary miRNAs as biomarkers for chronic kidney disease (CKD) in these companion animals. We introduce miRNAs, their biogenesis, and their presence in biofluids, particularly within exosomes, and discuss studies investigating miRNAs in kidney tissue and urine. We acknowledge the challenges associated with miRNA studies, including preanalytical factors such as biological variation, sample collection/processing, storage conditions, and experimental design. We highlight the importance of technical considerations, such as sample pooling, sequencing depth, multiplexing, and the various steps of the miRNA experimental workflow. Furthermore, we discuss RNA isolation methods, small RNA sequencing data analysis, and the use of quantitative reverse transcription PCR (qRT‐PCR) and droplet digital PCR for verification. We emphasize the importance of internal controls, spike‐ins, and normalization methods to minimize technical variation and ensure reliable results in qRT‐PCR analysis. This review concludes that while urinary miRNAs hold promise as non‐invasive biomarkers for CKD in dogs and cats, addressing the challenges and standardization of protocols is vital for the successful translation of this research into clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Veterinary Pathobiology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas, USA.
ORCID-Profile: Candice P Chu
Zitieren
APA
Chu, C. P., & Nabity, M. B. (2025). Technical considerations and review of urinary microRNAs as biomarkers for chronic kidney disease in dogs and cats. Veterinary Clinical Pathology. https://doi.org/10.1111/vcp.13412
Vancouver
Chu CP, Nabity MB. Technical considerations and review of urinary microRNAs as biomarkers for chronic kidney disease in dogs and cats. Veterinary Clinical Pathology. 2025. doi:10.1111/vcp.13412
BibTeX
@article{Chu2025,
author = {Chu, Candice P and Nabity, Mary B},
title = {Technical considerations and review of urinary microRNAs as biomarkers for chronic kidney disease in dogs and cats},
journal = {Veterinary Clinical Pathology},
year = {2025},
doi = {10.1111/vcp.13412}
}
EUVIMED